Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
12-week, randomized, double-blind, placebo-controlled, parallel-group study of carbetocin nasal spray for the treatment of hyperphagia in Prader-Willi syndrome (PWS)
Epistemonikos ID: b3aca57fe28e949fbbb6a924733caabf6bce75f6
First added on: May 15, 2024